[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Leprosy Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 115 pages | ID: G4C5A3AA82AGEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Leprosy, also known as Hansen's disease (HD), is a long-term infection by the bacterium Mycobacterium leprae or Mycobacterium lepromatosis. Initially, infections are without symptoms and typically remain this way for 5 to 20 years. Symptoms that develop include granulomas of the nerves, respiratory tract, skin, and eyes. This may result in a lack of ability to feel pain, which can lead to the loss of parts of extremities due to repeated injuries or infection due to unnoticed wounds. Weakness and poor eyesight may also be present.

SCOPE OF THE REPORT:

This report studies the Leprosy Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Leprosy Treatment market by product type and applications/end industries.
The two main types of disease are based on the number of bacteria present: paucibacillary and multibacillary. The two types are differentiated by the number of poorly pigmented, numb skin patches present, with paucibacillary having five or fewer and multibacillary having more than five. The diagnosis is confirmed by finding acid-fast bacilli in a biopsy of the skin or by detecting the DNA using polymerase chain reaction.
The global Leprosy Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Leprosy Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
  • Glaxo Smithcline
  • Systopic Laboratories
  • Cadila Pharmaceuticals
  • Acme Pharmaceuticals
  • Macleods Pharmaceuticals
  • Novartis
  • Astra Zeneca
  • Lark Laboratories
Market Segment by Regions, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Colombia)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
  • Sulfone
  • Phenazine Derivative
  • Anti-Tubercular Drugs
  • Others
Market Segment by Applications, can be divided into
  • Hospitals
  • Clinics
  • Pharmacy
1 LEPROSY TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Leprosy Treatment
1.2 Classification of Leprosy Treatment by Types
  1.2.1 Global Leprosy Treatment Revenue Comparison by Types (2017-2023)
  1.2.2 Global Leprosy Treatment Revenue Market Share by Types in 2017
  1.2.3 Sulfone
  1.2.4 Phenazine Derivative
  1.2.5 Anti-Tubercular Drugs
  1.2.6 Others
1.3 Global Leprosy Treatment Market by Application
  1.3.1 Global Leprosy Treatment Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Pharmacy
1.4 Global Leprosy Treatment Market by Regions
  1.4.1 Global Leprosy Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Leprosy Treatment Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Leprosy Treatment Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Leprosy Treatment Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Leprosy Treatment Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Leprosy Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Leprosy Treatment (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Glaxo Smithcline
  2.1.1 Business Overview
  2.1.2 Leprosy Treatment Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Glaxo Smithcline Leprosy Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Systopic Laboratories
  2.2.1 Business Overview
  2.2.2 Leprosy Treatment Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Systopic Laboratories Leprosy Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Cadila Pharmaceuticals
  2.3.1 Business Overview
  2.3.2 Leprosy Treatment Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Cadila Pharmaceuticals Leprosy Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Acme Pharmaceuticals
  2.4.1 Business Overview
  2.4.2 Leprosy Treatment Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Acme Pharmaceuticals Leprosy Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Macleods Pharmaceuticals
  2.5.1 Business Overview
  2.5.2 Leprosy Treatment Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Macleods Pharmaceuticals Leprosy Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novartis
  2.6.1 Business Overview
  2.6.2 Leprosy Treatment Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Novartis Leprosy Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Astra Zeneca
  2.7.1 Business Overview
  2.7.2 Leprosy Treatment Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Astra Zeneca Leprosy Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Lark Laboratories
  2.8.1 Business Overview
  2.8.2 Leprosy Treatment Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Lark Laboratories Leprosy Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL LEPROSY TREATMENT MARKET COMPETITION, BY PLAYERS

3.1 Global Leprosy Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Leprosy Treatment Players Market Share
  3.2.2 Top 10 Leprosy Treatment Players Market Share
3.3 Market Competition Trend

4 GLOBAL LEPROSY TREATMENT MARKET SIZE BY REGIONS

4.1 Global Leprosy Treatment Revenue and Market Share by Regions
4.2 North America Leprosy Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Leprosy Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Leprosy Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Leprosy Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Leprosy Treatment Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA LEPROSY TREATMENT REVENUE BY COUNTRIES

5.1 North America Leprosy Treatment Revenue by Countries (2013-2018)
5.2 USA Leprosy Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Leprosy Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Leprosy Treatment Revenue and Growth Rate (2013-2018)

6 EUROPE LEPROSY TREATMENT REVENUE BY COUNTRIES

6.1 Europe Leprosy Treatment Revenue by Countries (2013-2018)
6.2 Germany Leprosy Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Leprosy Treatment Revenue and Growth Rate (2013-2018)
6.4 France Leprosy Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Leprosy Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Leprosy Treatment Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC LEPROSY TREATMENT REVENUE BY COUNTRIES

7.1 Asia-Pacific Leprosy Treatment Revenue by Countries (2013-2018)
7.2 China Leprosy Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Leprosy Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Leprosy Treatment Revenue and Growth Rate (2013-2018)
7.5 India Leprosy Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Leprosy Treatment Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA LEPROSY TREATMENT REVENUE BY COUNTRIES

8.1 South America Leprosy Treatment Revenue by Countries (2013-2018)
8.2 Brazil Leprosy Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Leprosy Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Leprosy Treatment Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE LEPROSY TREATMENT BY COUNTRIES

9.1 Middle East and Africa Leprosy Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Leprosy Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Leprosy Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Leprosy Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Leprosy Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Leprosy Treatment Revenue and Growth Rate (2013-2018)

10 GLOBAL LEPROSY TREATMENT MARKET SEGMENT BY TYPE

10.1 Global Leprosy Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Leprosy Treatment Market Forecast by Type (2018-2023)
10.3 Sulfone Revenue Growth Rate (2013-2023)
10.4 Phenazine Derivative Revenue Growth Rate (2013-2023)
10.5 Anti-Tubercular Drugs Revenue Growth Rate (2013-2023)
10.6 Others Revenue Growth Rate (2013-2023)

11 GLOBAL LEPROSY TREATMENT MARKET SEGMENT BY APPLICATION

11.1 Global Leprosy Treatment Revenue Market Share by Application (2013-2018)
11.2 Leprosy Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Pharmacy Revenue Growth (2013-2018)

12 GLOBAL LEPROSY TREATMENT MARKET SIZE FORECAST (2018-2023)

12.1 Global Leprosy Treatment Market Size Forecast (2018-2023)
12.2 Global Leprosy Treatment Market Forecast by Regions (2018-2023)
12.3 North America Leprosy Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Leprosy Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Leprosy Treatment Revenue Market Forecast (2018-2023)
12.6 South America Leprosy Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Leprosy Treatment Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source



LIST OF TABLES AND FIGURES

Figure Leprosy Treatment Picture
Table Product Specifications of Leprosy Treatment
Table Global Leprosy Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Leprosy Treatment Revenue Market Share by Types in 2017
Figure Sulfone Picture
Figure Phenazine Derivative Picture
Figure Anti-Tubercular Drugs Picture
Figure Others Picture
Table Global Leprosy Treatment Revenue (Million USD) by Application (2013-2023)
Figure Leprosy Treatment Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Pharmacy Picture
Table Global Market Leprosy Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Leprosy Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Leprosy Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Leprosy Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Leprosy Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Leprosy Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Leprosy Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table Glaxo Smithcline Basic Information, Manufacturing Base and Competitors
Table Glaxo Smithcline Leprosy Treatment Type and Applications
Table Glaxo Smithcline Leprosy Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Systopic Laboratories Basic Information, Manufacturing Base and Competitors
Table Systopic Laboratories Leprosy Treatment Type and Applications
Table Systopic Laboratories Leprosy Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Cadila Pharmaceuticals Leprosy Treatment Type and Applications
Table Cadila Pharmaceuticals Leprosy Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Acme Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Acme Pharmaceuticals Leprosy Treatment Type and Applications
Table Acme Pharmaceuticals Leprosy Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Macleods Pharmaceuticals Leprosy Treatment Type and Applications
Table Macleods Pharmaceuticals Leprosy Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Leprosy Treatment Type and Applications
Table Novartis Leprosy Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table Astra Zeneca Leprosy Treatment Type and Applications
Table Astra Zeneca Leprosy Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Lark Laboratories Basic Information, Manufacturing Base and Competitors
Table Lark Laboratories Leprosy Treatment Type and Applications
Table Lark Laboratories Leprosy Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Leprosy Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Leprosy Treatment Revenue Share by Players (2013-2018)
Figure Global Leprosy Treatment Revenue Share by Players in 2016
Figure Global Leprosy Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Leprosy Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Leprosy Treatment Revenue Market Share in 2017
Figure Global Leprosy Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Leprosy Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Leprosy Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Leprosy Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Leprosy Treatment Revenue Market Share by Regions in 2017
Figure North America Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure South America Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Leprosy Treatment Revenue and Growth Rate (2013-2018)
Table North America Leprosy Treatment Revenue by Countries (2013-2018)
Table North America Leprosy Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Leprosy Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Leprosy Treatment Revenue Market Share by Countries in 2017
Figure USA Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Leprosy Treatment Revenue and Growth Rate (2013-2018)
Table Europe Leprosy Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Leprosy Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Leprosy Treatment Revenue Market Share by Countries in 2017
Figure Germany Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure UK Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure France Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Leprosy Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Leprosy Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Leprosy Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Leprosy Treatment Revenue Market Share by Countries in 2017
Figure China Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure India Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Leprosy Treatment Revenue and Growth Rate (2013-2018)
Table South America Leprosy Treatment Revenue by Countries (2013-2018)
Table South America Leprosy Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Leprosy Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Leprosy Treatment Revenue Market Share by Countries in 2017
Figure Brazil Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Leprosy Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Leprosy Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Leprosy Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Leprosy Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Leprosy Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Leprosy Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Leprosy Treatment Revenue and Growth Rate (2013-2018)
Table Global Leprosy Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Leprosy Treatment Revenue Share by Type (2013-2018)
Figure Global Leprosy Treatment Revenue Share by Type (2013-2018)
Figure Global Leprosy Treatment Revenue Share by Type in 2017
Table Global Leprosy Treatment Revenue Forecast by Type (2018-2023)
Figure Global Leprosy Treatment Market Share Forecast by Type (2018-2023)
Figure Global Sulfone Revenue Growth Rate (2013-2018)
Figure Global Phenazine Derivative Revenue Growth Rate (2013-2018)
Figure Global Anti-Tubercular Drugs Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Leprosy Treatment Revenue by Application (2013-2018)
Table Global Leprosy Treatment Revenue Share by Application (2013-2018)
Figure Global Leprosy Treatment Revenue Share by Application (2013-2018)
Figure Global Leprosy Treatment Revenue Share by Application in 2017
Table Global Leprosy Treatment Revenue Forecast by Application (2018-2023)
Figure Global Leprosy Treatment Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Pharmacy Revenue Growth Rate (2013-2018)
Figure Global Leprosy Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Leprosy Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Leprosy Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Leprosy Treatment Revenue Market Forecast (2018-2023)
Figure Europe Leprosy Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Leprosy Treatment Revenue Market Forecast (2018-2023)
Figure South America Leprosy Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Leprosy Treatment Revenue Market Forecast (2018-2023)


More Publications